Serum biochemical markers are powerful tools for the evaluation of bone turnover. Inthis study, we developed a radioimmunoassay, using a synthetic peptide for the N-terminal fragment of human type I [al (I)] procollagen (N-PCP). A 14-amino acid peptide was synthesized from the amino terminus and used to generate antibodies in rabbits. The synthetic peptide was used as standard and tracer in the assay. Both native type I amino procollagen (PINP), which was purified from skin fibroblasts, and human serum displaced tracer binding in parallel with the synthetic peptide. The range for measurement of N-PCP in serum was 0.7 to 30 g/L (0.21-9.18 nmol/L). In a sample of 17 normal adults and 13 children (ages 9-16 years) there was a strong correlation between serum N-PCP determined by this assay and both skeletal alkaline phosphatase isoenzyme and osteocalcin, markers of bone formation.
group of normal children were eightfold higher than concentrations in normal adults, with no overlap between the two groups. N-PCP also correlated with C-terminal type I procollagen determined with a commercially available kit (r= 0.92).
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Bone turnover is a dynamic process involving continuous resorption and production of bone matrix. Type I collagen is a major component of bone, accounting for >90% of bone matrix protein content. Each collagen fiber is composed of three long, helical polypeptide chains (a chains) that bind tightly to each other. The large amino-and carboxyl-terminal ends of the procollagen are important in the alignment and assembly of the trimer, and perhaps in determining the collagen fibril diameters (1). The N-and C-terminal propeptides are deaved extracellularly from mature collagen before fibril assembly, released into the extracellular fluid, and cleared in the circulation. Thus the concentrations of these propeptide fragments in the blood may be correlated with the rate of bone formation, and determination of these concentrations maybe of diagnostic value. studies of diseases of liver, skin, inflammatory bowel, and bone (2) (3) (4) (5) . Although type I collagen is found in other tissues, it is assumed that the rate of turnover for these tissues is low relative to that for bone and, therefore, changes in serum type I procollagen presumably reflect primarily changes in the rate of bone collagen biosynthesis, and thus changes in the rate of bone formation.
Most When a sufficient titer had been reached to develop a competitive binding assay (determined by binding I-labeled peptide), the antiserum was tested with several peptides as well as with the native protein to assess specificity. Borate buffer (0.05 mol/L with 1 g/L bovine serum albumin, pH 8.4), was used for the RIAs performed here. The synthetic peptide was iodinated by the Chioramine T method (14) , and the assay was set up as follows: 25 L of standard (either peptide or the native procollagen N-terminal fragment) or unknown was incubated with 250 pL of the borate buffer and 100 pL of radioactive tracer (-30 000 counts/ mm). Antiserum was added last and the samples were then incubated for 1 h at 4#{176}C. To assess specificity, we tested the binding of two synthetic peptides to regions of the C terminus of procollagen 1(I) (GSNEIEIR, NV-VRDRDLEVDT) and native C-terminal propeptide. To determine parallel displacements, we made serial dilutions of serum samples and generated standard displacement curves, using both the peptide and the native procollagen N-terminal fragment (PINP) purified from human fibroblast cultures (a gift of J. Risteli, University of Oulu, Finland). After secondary precipitation with normal rabbit serum and either goat antiserum to rabbit IgG or purified antibody to rabbit Ig, the radioactivity in the pellets was counted in a Micromedic gamma counter (ICN Biomedicals, Costa Mesa, CA). To determine whether inhibitors were present that might interfere with an accurate quantitation of procollagen, we added a known amount of procollagen peptide to the serum samples and then serially diluted them.
Patient population.
Serum samples were collected from 13 children (ages 9-16 years) and 17 normal adults (ages years) in accordance with a protocol approved by a Human Subjects Review Board.
Other serum assays. Skeletal alkaline phosphatase (sALP) was determined by the method of Farley et al. (15) . Serum osteocalcin (OSC) was determined by an RIA developed in this laboratory (16). A C-terminal collagen type I (PICP) RIA kit was purchased from Incatar (Stillwater, MN).
Statistics.
To evaluate the clinical performance of the different tests, we estimated both the accuracy and the discriminant power of each assay in distinguishing subjects with different bone formation rates (adults vs children). The accuracy was estimated as the area ± standard error under the receiver-operating characteristic (ROC) curve (17), and the discriminant power was estimated as a z score. Relative differences between groups and between assays were tested by using paired and unpaired Student's t-tests, respectively.
Results

Specificity and Characteristics of the Assay
The antibodies generated to the N-PCP peptide, together with use of this synthetic peptide as tracer and standard, gave similar displacement curves for human serum and the native protein fragment, PINP (Figure  1) . The parallel displacement curves suggest that the antibodies to the peptides were measuring the native protein. The range of the assay (80% confidence levels) was 0.7-30 ig of peptide per liter (0.21 to 9.18 nmol/L). The intraassay variation was 7% on values with a B/B0 ratio of 0.25-0.65, and the interassay variation was 17%. Given this high interassay variation, all samples being compared were always run in the same assay. There was no displacement of labeled antibody binding by the 29-36 N-terminal peptide or by peptides made to the C terminus of type I procollagen. There was also no difference in values related to the secondary precipitating antibodies.
Sera from several animal species were tested to determine species specificity (Figure 2 ). All animal sera tested showed displacement and a change in binding with dilution, indicating some cross-reactivity with the human sequence. Goat serum had the most measurable N-PCP, but, like serum from the other species, did not dilute in parallel with the standard or human sera. However, the assay may be useful in some animal models.
The antibodies produced to the N-PCP synthetic pep- sulfate-polyacrylamide gel electrophoresis and assessed by Western blotting to determine whether the antiserum detected multiple N-terminal procollagen fragments. There were bands at -100,34, and 27 kDa, with no detectable smaller fragments.
N-PCP, PICP, OSC, and sALP Measurement in Adults and
Children
The N-PCP assay was used to determine serum procollagen concentrations in a group of normal subjects, ages 9-60 years. These results were then compared with serum concentrations of PICP, OSC, and sALP in the same subjects. The N-PCP concentration was high for ages corresponding to the expected time of the pubertal growth spurt and then decreased sharply to adult levels (Figure 3) .
The mean N-PCP value (± SEM) of the adult sera was 1.75 ± 0.17 nmol/L (synthetic peptide equivalents), whereas the mean for the children was 14.25 ± 2.55 nmol/L, a 8.1-fold increase that was significantly different by Student's t-test Table 1) . While there was a good correlation between N-PCP and PICP in children, there did appear to be some differences with age. The ratio of concentrations of the two propeptidea in serum differed in children and adults (Table 1) , and the decrease in PICP with maturation was less (69.4 ± 9.7%) than the decrease in N-PCP (87.3 ± 4.8%, P <0.05).
To determine whether the N-PCP assay correlated with other markers of bone formation, we examined the relation of N-PCP to PICP, sALP, and OSC. 
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The discriminant powers of the N-PCP, PICP, sALP, and OSC were studied by means of ROC analysis (Table  3) . There was no statistically significant difference between the two procollagen assays in accuracy or diacriminant power to distinguish the two groups of subjects. Nor did the OSC or sALP assays differ sigi iflnantly from the procollagen assays in discriminant power. 
Numbers show means ± SD for each group. The differencebetweenadults and children Is P <0.001 for all assays and for the PICP/N-PCP ratio. 
Discussion
Serum assays of sALP, OSC, PICP, and PINP developed to assess bone formation are of value in the diagnosis, management, and treatment of metabolic bone disease (18) . However, each assay has certain limitations. Although sALP correlates with bone formation in many conditions, the function of the enzyme in bone formation is unknown, and release of the enzyme from bone may not be directly related to bone matrix biosynthesis. Total serum ALP includes enzymes from tissues other than bone, notably liver, and determination of aALP requires complex kinetic assays (15) or specific ixnmunoassays (19) . Furthermore, in some conditions, such as vitamin D deficiency and osteomsilacia, serum sALP is elevated while bone formation is not (20) . Studies of osteoblasts in vitro have shown that ALP is induced by l,25-dihydroxyvitamin D3, whereas collagen synthesis is not (21).
OSC is incorporated into bone matrix, and thus the excess OSC produced and released into the blood may be directly related to the rate of bone formation. However, the relative extent to which newly synthesized OSC is released into the blood or incorporated into bone matrix could be affected by different dinical conditions. Since OSCisinbonematrix,OSCinbloodmayalsobederived from OSC released from bone matrix during resorption ( 
18,22,23).
Like ALP, production of OSC is induced by 1,25-dihydroxyvitamin D3. Serum OSC does not correlate with bone formation rate in patients treated with high doses of 1,25-dihydroxyvitamin D3, in immobilized patients, or in patients with renal failure (18,23,24) .
Since collagen constitutes >90% of bone matrix protein, and since the procollagen peptide fragments are released rather than incorporated into bone matrix, serum procollagen peptide concentrations may more directly measure bone matrix biosynthesis and assess bone formation than does sALP or OSC. Procollagen Table 2 . Correlation Coefficients , P <0.05;" , P <0.01; P <0.001; ns, not significant peptide assays may also be advantageous in assessing clinical conditions that specifically affect collagen production, e.g., conditions requiring treatment with glucocorticoids, which inhibit osteoblast collagen synthesis. One important limitation of procollagen peptide assays for evaluating bone formation, however, is that these assays measure procollagen fragments released not only from bone but from other sites as well. Although the amount of type I collagen produced in bone probably exceeds amounts produced in all other tissues in adults, the exact proportion produced in bone is unknown. Another potential limitation of procollagen peptide assays is that serum concentrations may be affected by degradation and excretion. However, the apparently equimolar ratio of N-PCP and PICP in normal adUlts suests that the two fragments do not have very different clearance rates. The strong correlation of N-PCP concentrations with ALP and OSC in healthy individuals also supports the conclusion that N-PCP concentrations are determined principally by bone formation rate rather than procollagen peptide degradation and clearance rates.
In the present study, both N-PCP and PICP were increased in serum from children compared to adults. However, the ratio of N-PCP to PICP in children was different from that in adults, with a greater relative change in N-PCP than PICP between the groups. This finding, and the difference in correlation coefficients with sALP and OSC, suests that the metabolism of the two propeptides in children undergoing rapid growth differs from that in adults with steady-state turnover.
Recently, a significant diurnal variation in PICP concentrations was observed, with 20% higher concentrations occurring at night (25) . It is not known whether a similar variation occurs in N-PCP concentration. Concentrations of N-PCP in adult serum were comparable, on a molar basis, with PICP concentrations, which were similar to normal adult concentrations (determined with the same commercial assay) reported in other studies (6, 12,25) . In contrast to our results, Ebeling et al. (12) found normal adult N-PCP concentrations that were nearly 100-fold higher than PICP concentrations and nearly 100-fold higher than the N-PCP concentrations determined by our assay. Ebeling et al. used an ELISA with an antiserum to a synthetic peptide corresponding to amino acids 29-45 of aj(I) preprocollagen, which overlapped the C-terminal half of the peptide that we used. Since the assay used by Ebeling et al. did not detect differences in N-PCP concentrations between children (ages 10-14 years) and adults, whereas all four bone formation markers assayed in the present study showed highly significant differences between the two populations, the region of the molecule they selected for their assay may not accurately reflect procollagen concentrations in serum.
Total body calcium kinetics determined by isotope turnover, and histomorphometiy of bone biopsies, have been considered gold standards for measurement of bone formation and resorption. Thus, it would be important to compare a new serum biochemical marker for bone formation to these standard measurements.
However, beyond the obvious technical difficulties of using human subjects, each method also has its own intrinsic uncertainties and limitations. For example, bone biopsy data reflect only the trsbecular bone site from where the biopsy is taken, whereas a serum biochemical marker measures an integrated value derived from activities of the entire skeleton. There are further uncertainties with respect to the validity of calcium isotope accretion measurements of bone formation, particularly in determining how much of the isotope is incorporated as a result of mineral deposition and how much is due to long-term axthange. The limitations of the "gold standards" for bone formation make it necessary to indirectly validate serum assays for bone formation by evaluating the performance of the assays under various metabolic conditions in which changes in bone formation are known to occur. By this rationale, the eightfold difference in N-PCP concentrations between normal children and adults, and the strong correlation of N-PCP and ALP concentrations, support the conclusion that N-PCP concentrations are a valid measure of the bone formation rate.
